Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin-Reference-Cited by-同舟云学术

Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin

Published:2008-07 Issue:6 Volume:154 Page:1225-1235
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Xavier F E,Aras-López R,Arroyo-Villa I,Del Campo L,Salaices M,Rossoni L V,Ferrer M,Balfagón G

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/bjp.2008.200/fullpdf

Reference27 articles.

1. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses;Alvarez;J Hypertens,2005

2. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats;Blanco-Rivero;Hypertension,2005

3. The role of thromboxane A2 in the altered microvascular reactivity in two-kidney, one-clip hypertension;Carvalho;Endothelium,1997

4. Biphasic action of prostacyclin in the human coronary artery;Davis;Clin Res,1980

5. Aldosterone and vascular damage;Duprez;Curr Hypertens Rep,2000

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid receptors contribute to ethanol-induced vascular hypercontractility through reactive oxygen species generation and up-regulation of cyclooxygenase 2;European Journal of Pharmacology;2023-06

2. Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story;Experimental and Clinical Endocrinology & Diabetes;2023-04-13

3. Autoregulation: mediators and renin–angiotensin system in diseases and treatments;Future Journal of Pharmaceutical Sciences;2023-04-07

4. Cyclooxygenase-2 is a critical determinant of angiotensin II-induced vascular remodeling and stiffness in resistance arteries of ouabain-treated rats;Journal of Hypertension;2022-08-08

5. Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage;Clinical Science;2022-05